Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.

Gill KE, Pierre PJ, Daunais J, Bennett AJ, Martelle S, Gage HD, Swanson JM, Nader MA, Porrino LJ.

Neuropsychopharmacology. 2012 Nov;37(12):2555-65. doi: 10.1038/npp.2012.117. Epub 2012 Jul 18.

2.

Serum and brain concentrations of methylphenidate: implications for use and abuse.

Swanson JM, Volkow ND.

Neurosci Biobehav Rev. 2003 Nov;27(7):615-21. Review.

PMID:
14624806
3.

Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.

Volkow ND, Fowler JS, Wang GJ, Ding YS, Gatley SJ.

Eur Neuropsychopharmacol. 2002 Dec;12(6):557-66. Review.

PMID:
12468018
4.

Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans.

Volkow ND, Fowler JS, Wang GJ.

J Psychopharmacol. 1999 Dec;13(4):337-45. Review.

PMID:
10667609
5.

Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.

Volkow ND, Swanson JM.

Am J Psychiatry. 2003 Nov;160(11):1909-18. Review.

PMID:
14594733
6.

Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine.

Heal DJ, Gosden J, Smith SL.

Neuropharmacology. 2014 Dec;87:19-40. doi: 10.1016/j.neuropharm.2014.06.012. Epub 2014 Jun 19. Review.

PMID:
24953830
7.

PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.

Gould RW, Duke AN, Nader MA.

Neuropharmacology. 2014 Sep;84:138-51. doi: 10.1016/j.neuropharm.2013.02.004. Epub 2013 Feb 28. Review.

8.
9.

Presynaptic dopamine modulation by stimulant self-administration.

Espana RA, Jones SR.

Front Biosci (Schol Ed). 2013 Jan 1;5:261-76. Review.

10.

Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence.

Dürsteler KM, Berger EM, Strasser J, Caflisch C, Mutschler J, Herdener M, Vogel M.

Subst Abuse Rehabil. 2015 Jun 17;6:61-74. doi: 10.2147/SAR.S50807. eCollection 2015. Review.

11.

Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.

Rothman RB, Blough BE, Baumann MH.

Exp Clin Psychopharmacol. 2008 Dec;16(6):458-74. doi: 10.1037/a0014103. Review.

12.

Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.

Howell LL, Negus SS.

Adv Pharmacol. 2014;69:129-76. doi: 10.1016/B978-0-12-420118-7.00004-4. Review.

13.

[2[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]-oct-2-yl]-methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-N2,N2’,S2,S2]oxo-[1R-exo-exo)])- [99mTc]-technetium.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Apr 24 [updated 2007 Dec 20].

14.

William L. Woolverton: a case history in unraveling the behavioral pharmacology of stimulants.

Nader MA, Balster RL, Henningfield JE.

Neuropharmacology. 2014 Dec;87:4-8. doi: 10.1016/j.neuropharm.2014.05.004. Epub 2014 May 20. Review.

15.
16.

Cocaine's appetite for fat and the consequences on body weight.

Billing L, Ersche KD.

Am J Drug Alcohol Abuse. 2015 Mar;41(2):115-8. doi: 10.3109/00952990.2014.966196. Epub 2014 Oct 16. Review.

PMID:
25321424
17.

Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations.

Huskinson SL, Naylor JE, Rowlett JK, Freeman KB.

Neuropharmacology. 2014 Dec;87:66-80. doi: 10.1016/j.neuropharm.2014.03.009. Epub 2014 Mar 22. Review.

18.

Translating positron emission tomography studies in animals to stimulant addiction: promises and pitfalls.

Caprioli D, Fryer TD, Sawiak SJ, Aigbirhio FI, Dalley JW.

Curr Opin Neurobiol. 2013 Aug;23(4):597-606. doi: 10.1016/j.conb.2013.04.003. Epub 2013 May 9. Review.

PMID:
23664005
19.

Intravenous Drug Self-Administration in Nonhuman Primates.

Howell LL, Fantegrossi WE.

In: Buccafusco JJ, editor. Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2009. Chapter 9.

20.
Items per page

Supplemental Content

Write to the Help Desk